Literature DB >> 16298835

The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).

Joanne Ross1, Maree Teesson, Shane Darke, Michael Lynskey, Robert Ali, Alison Ritter, Richard Cooke.   

Abstract

The current study aimed to describe the characteristics (demographics, drug use, mental and physical health) of entrants to treatment for heroin dependence in three treatment modalities; and to compare these characteristics with heroin users not in or seeking treatment. Participants were 825 current heroin users recruited from Sydney, Adelaide and Melbourne: 277 entering methadone/buprenorphine maintenance treatment (MT), 288 entering detoxification (DTX), 180 entering drug-free residential rehabilitation (RR) and 80 not in treatment (NT). Treatment entrants were generally long-term heroin users with previous treatment experience. The majority of the sample (55%) were criminally active in the month preceding interview. Injection-related health problems (74%) and a history of heroin overdose (58%) were commonly reported. There were high degrees of psychiatric co-morbidity, with 49% reporting severe psychological distress, 28% having current major depression, 37% having attempted suicide and 42% having a lifetime history of post-traumatic stress disorder. Personality disorders were also prevalent, with 72% meeting criteria for antisocial personality disorder and 47% screening positive for borderline personality disorder. Striking similarities were noted between the non-treatment and treatment groups in length of heroin use career, drug use and treatment histories.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16298835     DOI: 10.1080/09595230500286039

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  52 in total

1.  Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment.

Authors:  Jonathan D Savant; Declan T Barry; Christopher J Cutter; Michelle T Joy; An Dinh; Richard S Schottenfeld; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2012-07-06       Impact factor: 4.492

2.  Adult attachment style is associated with cerebral μ-opioid receptor availability in humans.

Authors:  Lauri Nummenmaa; Sandra Manninen; Lauri Tuominen; Jussi Hirvonen; Kari K Kalliokoski; Pirjo Nuutila; Iiro P Jääskeläinen; Riitta Hari; Robin I M Dunbar; Mikko Sams
Journal:  Hum Brain Mapp       Date:  2015-06-05       Impact factor: 5.038

3.  Exploration of the telescoping effect among not-in-treatment, intensive heroin-using research volunteers.

Authors:  Jonathan J K Stoltman; Eric A Woodcock; Jamey J Lister; Mark K Greenwald; Leslie H Lundahl
Journal:  Drug Alcohol Depend       Date:  2015-01-19       Impact factor: 4.492

4.  Perceived stress and substance use in methadone-maintained smokers.

Authors:  Ethan Moitra; Bradley J Anderson; Michael D Stein
Journal:  Drug Alcohol Depend       Date:  2013-08-26       Impact factor: 4.492

5.  Depressive symptoms and patterns of drug use among street youth.

Authors:  Scott E Hadland; Brandon D L Marshall; Thomas Kerr; Jiezhi Qi; Julio S Montaner; Evan Wood
Journal:  J Adolesc Health       Date:  2010-12-18       Impact factor: 5.012

6.  Profiles of psychiatric disorders among heroin dependent individuals in Changsha, China.

Authors:  Mei Yang; Yanhui Liao; Qiang Wang; Marek C Chawarski; Wei Hao
Journal:  Drug Alcohol Depend       Date:  2015-02-02       Impact factor: 4.492

7.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

8.  Predictors of social anxiety in an opioid dependent sample and a control sample.

Authors:  Fiona L Shand; Louisa Degenhardt; Elliot C Nelson; Richard P Mattick
Journal:  J Anxiety Disord       Date:  2010-01

9.  Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90).

Authors:  Icro Maremmani; Pier Paolo Pani; Matteo Pacini; Jacopo V Bizzarri; Emanuela Trogu; Angelo Gi Maremmani; Gilberto Gerra; Giulio Perugi; Liliana Dell'Osso
Journal:  Ann Gen Psychiatry       Date:  2010-04-13       Impact factor: 3.455

10.  Heroin delay discounting: Modulation by pharmacological state, drug-use impulsivity, and intelligence.

Authors:  Jonathan J K Stoltman; Eric A Woodcock; Jamey J Lister; Leslie H Lundahl; Mark K Greenwald
Journal:  Exp Clin Psychopharmacol       Date:  2015-12       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.